The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1562
December 17, 2018
View Complete Issue         Table of Contents 2019 
Drugs for Chronic Insomnia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Chronic Insomnia
December 17, 2018 (Issue: 1562)
Cognitive behavioral therapy for insomnia (CBT-I) is recommended for initial treatment of chronic insomnia. Pharmacologic treatment should be used in addition to CBT-I when CBT-I alone is not effective.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Chronic Insomnia
Article code: 1562a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.